News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Newman Michael James
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 01/20/2023 |
4
| Newman Michael James (CSO and Director) has filed a Form 4 on Indaptus Therapeutics, Inc.|
Txns:
| Granted 43,250 options to buy
@ $1.61, valued at
$69.6k
|
|
| 02/02/2022 |
4
| Newman Michael James (CSO and Director) has filed a Form 4 on Indaptus Therapeutics, Inc.|
Txns:
| Sold 5,870 shares
@ $5.0001, valued at
$29.4k
Sold 14,130 shares
@ $5.003, valued at
$70.7k
|
|
| 01/28/2022 |
4
| Newman Michael James (CSO and Director) has filed a Form 4 on Indaptus Therapeutics, Inc.|
Txns:
| Granted 43,350 options to buy
@ $4.9, valued at
$212.4k
|
|
| 10/26/2021 |
SC 13D/A
| Newman Michael James reports a 16.9% stake in Indaptus Therapeutics, Inc. |
| 08/13/2021 |
SC 13D
| Form SC 13D - General statement of acquisition of beneficial ownership: |
| 08/06/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/06/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
|
|